GlassScriptPhysician profile
Tiffany Lin
NPI 1841672169
$2,014.58
in general payments reported to CMS, 2019-2025
10 companies · $246 in 2025
The $246 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $331 · 2020: $220 · 2021: $12.10 · 2022: $648 · 2023: $558 · 2025: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $804.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $803.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $578.49 | 2020-2023 | Sprint Pns System |
| Stryker Corporation | $447.73 | 2022 | |
| Abbvie INC. | $380.68 | 2023-2025 | |
| Boston Scientific Corporation | $154.70 | 2025 | Intracept |
| Nevro Corp. | $120.83 | 2019 | |
| Abbott Laboratories | $120.72 | 2019 | |
| Si-Bone, INC. | $97.08 | 2022 | |
| Medtronic USA, INC. | $89.10 | 2019 | |
| Avion Pharmaceuticals | $13.15 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.